 Contract
June 14, 2024
Chijet Motor s Subsidiary FAW Jilin Automobile Enters Framework Cooperation Agreement with Uzbekistan’s Sayyed Karimov In a recent strategic development, Chijet Motor Company, Inc. announced that its majority-owned subsidiary, FAW Jilin Automobile Co., Ltd. (FAW), has entered into a framework cooperation agreement...
|
Contract
June 14, 2024
Diana Shipping Inc. (NYSE: DSX), a global shipping company with a focus on the ownership and chartering of dry bulk vessels, recently announced a key development that signals both opportunity and caution for investors and stakeholders. The company has secured a time charter contract for its Kamsarmax dry bulk vessel...
|
Financing Agreement
June 14, 2024
In a significant move towards advancing its mission of revolutionizing the treatment landscape for serious hematologic diseases, Disc Medicine, Inc., a prominent clinical-stage biopharmaceutical company, has announced the pricing of an underwritten offering of its common stock. This offering paves the way ...
|
|
 Business Update
June 14, 2024
SLB Forges Ahead in Sustainability and Energy Solutions with Two Strategic Endeavours SLB (NYSE: SLB), a global technology company, has recently achieved significant strides toward fostering a sustainable future and advancing technological innovation in the energy sector. The announcements of two major initiatives u...
 Business Update
June 14, 2024
Glaukos Corporation s Strategic Exchange Agreements Pave the Path for Growth and SuccessALISO VIEJO, Calif. - Glaukos Corporation (NYSE: GKOS), the renowned ophthalmic pharmaceutical and medical technology company, has recently taken a significant step towards strengthening its financial position and unlocking furth...
|
|
Our most Popular Articles
|
Product Service News
February 28, 2024
Red Cat Partners with Primordial Labs to Integrate AI-Driven Voice Control Technology into its PlatformSAN JUAN, Puerto Rico, Feb. 28, 2024 - Red Cat Holdings, Inc. (Nasdaq: RCAT), a leading drone technology company specializing in robotic hardware and software for military, government, and commercial operations, ha...
|
Management Announcement
July 16, 2024
LOBO EV Expands into Suriname, Bolsters Electric Mobility Solutions in Latin America
Suriname witnesses the establishment of a new chapter in sustainable transportation as LOBO EV, a renowned electric vehicle (EV) manufacturer, sets up its office in the country. This strategic move, informed by the rising deman...
|
Product Service News
August 13, 2024
BBSI Expands Operations to Pocatello Amid Mixed Market Performance VANCOUVER, Wash., Aug. 12, 2024 Barrett Business Services, Inc. (NASDAQ: BBSI), a leading provider of business management solutions and professional employer organization (PEO) services in the United States, announced its entry into the Pocatello, ...
|
|
|
Company News
|
Contract
June 14, 2024
Diana Shipping Inc. (NYSE: DSX), a global shipping company with a focus on the ownership and chartering of dry bulk vessels, recently announced a key development that signals both opportunity and caution for investors and stakeholders. The company has secured a time charter contract for its Kamsarmax dry bulk vessel...
|
Financing Agreement
June 14, 2024
In a significant move towards advancing its mission of revolutionizing the treatment landscape for serious hematologic diseases, Disc Medicine, Inc., a prominent clinical-stage biopharmaceutical company, has announced the pricing of an underwritten offering of its common stock. This offering paves the way ...
|
Product Service News
June 14, 2024
CSIMarket.com LiveOne Teams Up with Soccer Legends Ronaldinho and Kaka for a Star-Studded MASL Celebrity Match LiveOne (Nasdaq: LVO), a premium platform for livestream and on-demand audio, video, and podcast content in music, comedy, and pop culture, has once again proven its prowess in the realm of live entertai...
|
|
|
Company News
 Clinical Study
June 14, 2024
|
Company News
 Clinical Study
June 14, 2024
|
Company News
 Financing Agreement
June 14, 2024
|
More Company News
|
Business Update
June 14, 2024
|
Management Announcement
June 14, 2024
|
Clinical Study
June 14, 2024
|
Clinical Study
June 14, 2024
|
Clinical Study
June 14, 2024
|
Product Service News
June 14, 2024
|
Clinical Study
June 14, 2024
|
Clinical Study
June 14, 2024
|
Business Update
June 14, 2024
|
Business Update
June 14, 2024
|
|
|
|
Related News
|
Contract
|
Clinical Study
|
|
Stocks
|
Business Update
|
Business Update
|
Business Update
|
|
|
|
Business News
|
|
Business Update
SLB Forges Ahead in Sustainability and Energy Solutions with Two Strategic Endeavours SLB (NYSE: SLB), a global technology company, has recently achieved significant strides toward fostering a sustainable future and advancing technological innovation in the energy sector. The announcements of two major initiatives u...
|
|
Business Update
Glaukos Corporation s Strategic Exchange Agreements Pave the Path for Growth and SuccessALISO VIEJO, Calif. - Glaukos Corporation (NYSE: GKOS), the renowned ophthalmic pharmaceutical and medical technology company, has recently taken a significant step towards strengthening its financial position and unlocking furth...
|
 Business Update
AmeriServ Financial Inc. (NASDAQ: ASRV), a financial institution based in Johnstown, Pennsylvania, has announced a significant cooperation and settlement agreement with Driver Opportunity Partners I LP, a notable stakeholder in the company. This strategic collaboration emerges as AmeriServ continues to exhibit robus...
|
|
Product Service News
In a year marked by rapid advancements in life sciences, OneMedNet Corporation (Nasdaq: ONMD) is making waves with a series of strategic moves that could redefine the landscape of Real World Data (RWD) utilization in clinical trials. The company s recent announcements highlight a significant partnership, unprecedent...
|
 Contract
Chijet Motor s Subsidiary FAW Jilin Automobile Enters Framework Cooperation Agreement with Uzbekistan’s Sayyed Karimov In a recent strategic development, Chijet Motor Company, Inc. announced that its majority-owned subsidiary, FAW Jilin Automobile Co., Ltd. (FAW), has entered into a framework cooperation agreement...
|
Our Most Popular Articles
|
 Product Service News
Red Cat Partners with Primordial Labs to Integrate AI-Driven Voice Control Technology into its PlatformSAN JUAN, Puerto Rico, Feb. 28, 2024 - Red Cat Holdings, Inc. (Nasdaq: RCAT), a leading drone technology company specializing in robotic hardware and software for military, government, and commercial operations, ha...
|
 Management Announcement
LOBO EV Expands into Suriname, Bolsters Electric Mobility Solutions in Latin America
Suriname witnesses the establishment of a new chapter in sustainable transportation as LOBO EV, a renowned electric vehicle (EV) manufacturer, sets up its office in the country. This strategic move, informed by the rising deman...
|
 Product Service News
BBSI Expands Operations to Pocatello Amid Mixed Market Performance VANCOUVER, Wash., Aug. 12, 2024 Barrett Business Services, Inc. (NASDAQ: BBSI), a leading provider of business management solutions and professional employer organization (PEO) services in the United States, announced its entry into the Pocatello, ...
|
More News
|
 Contract
Diana Shipping Inc. (NYSE: DSX), a global shipping company with a focus on the ownership and chartering of dry bulk vessels, recently announced a key development that signals both opportunity and caution for investors and stakeholders. The company has secured a time charter contract for its Kamsarmax dry bulk vessel...
|
 Financing Agreement
In a significant move towards advancing its mission of revolutionizing the treatment landscape for serious hematologic diseases, Disc Medicine, Inc., a prominent clinical-stage biopharmaceutical company, has announced the pricing of an underwritten offering of its common stock. This offering paves the way ...
|
 Product Service News
CSIMarket.com LiveOne Teams Up with Soccer Legends Ronaldinho and Kaka for a Star-Studded MASL Celebrity Match LiveOne (Nasdaq: LVO), a premium platform for livestream and on-demand audio, video, and podcast content in music, comedy, and pop culture, has once again proven its prowess in the realm of live entertai...
|
 Clinical Study
Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX) recently made groundbreaking progress regarding the understanding and treatment of Diabetic Peripheral Neuropathic Pain (DPNP). Three poster presentations were delivered during the 84th Scientific Sessions of the American Diabetes Association. These presentations shed lig...
|
 Clinical Study
Jasper Therapeutics, a leading clinical stage biotechnology company, has recently presented significant preclinical data at the 2024 European Hematology Association (EHA) Hybrid Congress in Madrid, Spain. The data showcased the remarkable effect of their novel antibody therapy, briquilimab, on hematopoietic stem cel...
|
 Financing Agreement
London-based clinical-stage biopharmaceutical company, Mereo BioPharma Group plc, has recently disclosed the pricing of its underwritten offering of 12,531,300 American Depositary Shares (ADSs). Priced at $3.99 per ADS, the offering is expected to generate approximately $50.0 million in gross proceeds. Mer...
|
 Business Update
In a heartwarming collaboration, BARK, a leading global omnichannel dog brand, joined forces with Military Makeover with Montel to transform the home of military veteran Matthew Kruspe and his family. Alongside this touching gesture, BARK also designed a specialized space for the Kruspe family s beloved rescue pit b...
|
 Management Announcement
Global technology company JOYY Inc. (Nasdaq: YY) recently announced the successful results of its repurchase right offer for its 1.375% Convertible Senior Notes due 2026. The offer saw a significant response, with a total of US$405,445,000 aggregate principal amount of the 2026 Notes surrendered and accept...
|
 Clinical Study
In their recent announcement, Cogent Biosciences revealed additional clinical data from Part 1 of the SUMMIT trial, showcasing the potential of bezuclastinib in patients with NonAdvanced Systemic Mastocytosis (NonAdvSM). The trial evaluated the efficacy and safety of this promising drug, and the results have generat...
|
 Clinical Study
Positive Clinical Data Across Disc Medicine s Portfolio Highlight Potential Advances in Hematologic Treatments BackgroundDisc Medicine, Inc. (NASDAQ: IRON), a clinical-stage biopharmaceutical company, has made significant strides in developing novel treatments for serious hematologic diseases. Their recent presenta...
|
 Clinical Study
The European Hematology Association (EHA) 2024 Hybrid Congress witnessed a groundbreaking revelation in the field of hematological research, as Aptose Biosciences presented remarkable clinical and preclinical findings for their drug Tuspetinib (TUS). These findings hold significant implications for the company s fut...
|
 Product Service News
Medicare Approves Coverage for KidneyIntelX.dkd: Significant Milestone for Chronic Kidney Disease ManagementIn a groundbreaking development aimed at revolutionizing chronic kidney disease (CKD) management, Medicare has issued a final coverage determination for KidneyIntelX.dkd, a pioneering diagnostic test designed...
|
|
Clinical Study
Unveiling the Promise of Targeted Protein Degradation: Kymera Therapeutics’ KT-333 Shines in Phase 1 Clinical Trial Kymera Therapeutics continues to make significant strides in the field of targeted protein degradation, a novel therapeutic approach that selectively removes disease-causing proteins. At the recent European Hematology Association (EHA) Annual Meeting, Kymera presented compelling new clinical data from its ongoing Phase 1 trial of KT-333, a selective STAT3 degrader. The results underscored the potential of KT-333 as a transformative treatment for various hematological malignancies, demonstrating not only safety and tolerability but also remarkable clinical efficacy. The Mechanism Behind KT-333KT-333 targets Signal Transducer and Activator of Transcription 3 (STAT3), a transcriptional regulator implicated in numerous cancer types, including hematological malignancies. Unlike traditional inhibitors, KT-333 employs a protein degradation mechanism that eliminates STAT3 from the cancer cell. This innovative approach has shown promise in preclinical studies by effectively reducing cancer cell proliferation and inducing apoptosis.
|
 Clinical Study
Bio-Path Holdings recently presented encouraging data from an ongoing phase 2 combination study of Prexigebersen at the European Hematology Association (EHA) Congress. The presentation highlighted positive outcomes from an interim analysis, revealing significant clinical improvement and a tolerable safety profile wh...
|
 Business Update
HENDERSON, Nev. Zura Bio Limited (Nasdaq: ZURA), an emergent force in the immunology field, has taken a significant stride forward with the release of encouraging data from its Phase 1 study of tibulizumab (ZB-106) at the Annual European Congress of Rheumatology (EULAR) 2024. This clinical-stage company is disting...
|
 Business Update
Manchester United To Invest £50M in Carrington Training Facility To Create a Winning Environment Amidst Corporate Revenue SurgeManchester, England Manchester United plc (NYSE: MANU) has announced a landmark investment of £50 million in their Carrington Training Complex, set to commence next week. This significan...
|
|
|
|
|
